KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Change in Accured Expenses (2016 - 2017)

Historic Change in Accured Expenses for Bio-Rad Laboratories (BIO) over the last 9 years, with Q3 2017 value amounting to $5.0 million.

  • Bio-Rad Laboratories' Change in Accured Expenses fell 8201.22% to $5.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $8.8 million, marking a year-over-year increase of 4428.2%. This contributed to the annual value of $28.6 million for FY2015, which is 38888.89% up from last year.
  • According to the latest figures from Q3 2017, Bio-Rad Laboratories' Change in Accured Expenses is $5.0 million, which was down 8201.22% from $37.0 million recorded in Q2 2017.
  • Bio-Rad Laboratories' Change in Accured Expenses' 5-year high stood at $41.0 million during Q3 2015, with a 5-year trough of -$61.2 million in Q1 2017.
  • For the 5-year period, Bio-Rad Laboratories' Change in Accured Expenses averaged around $1.6 million, with its median value being $6.2 million (2014).
  • In the last 5 years, Bio-Rad Laboratories' Change in Accured Expenses skyrocketed by 557527.88% in 2013 and then crashed by 51528.33% in 2016.
  • Bio-Rad Laboratories' Change in Accured Expenses (Quarter) stood at $13.9 million in 2013, then plummeted by 456.43% to -$49.6 million in 2014, then soared by 121.62% to $10.7 million in 2015, then soared by 160.17% to $27.9 million in 2016, then plummeted by 82.01% to $5.0 million in 2017.
  • Its Change in Accured Expenses was $5.0 million in Q3 2017, compared to $37.0 million in Q2 2017 and -$61.2 million in Q1 2017.